David M. Chacko
CFO & Chief Business OfficerDr. David M. Chacko, M.D. has been Chief Financial Officer of Erasca, Inc. since December 2020 and serves as its Chief Business Officer since April 2023 having joined Erasca in August 2019 as Chief Business Officer. Prior to Erasca, Dr. Chacko was a principal at Versant Ventures, a healthcare venture capital firm, from September 2017 to August 2019, where he led investment opportunities across multiple therapeutic areas and was intimately involved in advancing several Versant portfolio companies operationally through company formation, fundraising, corporate and business development and clinical and regulatory activities. Dr. Chacko joined Versant from Alcon, a multinational company specializing in eye care products, where he served as Chief of Staff to the Chief Executive Officer from 2014 to September 2017. Prior to Alcon, He was a management consultant at McKinsey & Company from 2011 to 2014. Dr. Chacko previously held positions at SR One, Amgen and Morgan Stanley. Dr. Chacko holds an M.D. from the University of Pennsylvania, an M.B.A. from the Wharton School of Business, an M. Phil. from Oxford University, where he was a Marshall Scholar and B.A. and B.S. degrees in biology and business from the University of Southern California, where he was the university valedictorian.
公司職務
- 公司名稱Erasca, Inc.股票代碼ERAS職務CFO & Chief Business Officer共事同僚
- JEJonathan E. LimCo-Founder, Chairman & CEO
- MDMichael D. VarneyChairman of Research & Development, Scientific Advisory Board Member and Director
- SRShannon R. MorrisChief Medical Officer
- ATAlison Tjosvold MilhousSenior Vice President of Accounting
- JAJames A. BristolLead Independent Director
- AWAlexander Whitman CasdinIndependent Director
- VHValerie Harding-StartIndependent Director
